Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression.

Hayakawa K, Formica AM, Brill-Dashoff J, Shinton SA, Ichikawa D, Zhou Y, Morse HC 3rd, Hardy RR.

J Exp Med. 2016 Dec 12;213(13):3007-3024. Epub 2016 Nov 29.

2.

Fetal Lymphoid Progenitors Become Restricted to B-1 Fates Coincident with IL-7Rα Expression.

Iida R, Shinoda K, Hayano Y, Nagai Y, Takatsu K, Kouro T.

PLoS One. 2016 Oct 28;11(10):e0165676. doi: 10.1371/journal.pone.0165676. eCollection 2016.

3.

Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the Aged.

Rothstein TL.

Front Immunol. 2016 Apr 7;7:127. doi: 10.3389/fimmu.2016.00127. eCollection 2016. Review.

4.

Perspectives on fetal derived CD5+ B1 B cells.

Hardy RR, Hayakawa K.

Eur J Immunol. 2015 Nov;45(11):2978-84. doi: 10.1002/eji.201445146. Epub 2015 Sep 23. Review.

5.

Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.

Ichikawa D, Asano M, Shinton SA, Brill-Dashoff J, Formica AM, Velcich A, Hardy RR, Hayakawa K.

J Immunol. 2015 Jan 15;194(2):606-14. doi: 10.4049/jimmunol.1402383. Epub 2014 Dec 5.

6.

Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow.

Reynolds AE, Kuraoka M, Kelsoe G.

J Immunol. 2015 Jan 1;194(1):231-42. doi: 10.4049/jimmunol.1401203. Epub 2014 Nov 26.

7.

Human B-1 cells take the stage.

Rothstein TL, Griffin DO, Holodick NE, Quach TD, Kaku H.

Ann N Y Acad Sci. 2013 May;1285:97-114. doi: 10.1111/nyas.12137. Review.

9.

Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions.

Wang H, Shin DM, Abbasi S, Jain S, Kovalchuk AL, Beaty N, Chen S, Gonzalez-Garcia I, Morse HC 3rd.

Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20077-82. doi: 10.1073/pnas.1212428109. Epub 2012 Nov 19.

10.

Immune response to lipoproteins in atherosclerosis.

Samson S, Mundkur L, Kakkar VV.

Cholesterol. 2012;2012:571846. doi: 10.1155/2012/571846. Epub 2012 Aug 23.

11.

Central B-cell tolerance: where selection begins.

Pelanda R, Torres RM.

Cold Spring Harb Perspect Biol. 2012 Apr 1;4(4):a007146. doi: 10.1101/cshperspect.a007146.

12.

Nutritionally mediated programming of the developing immune system.

Palmer AC.

Adv Nutr. 2011 Sep;2(5):377-95. doi: 10.3945/an.111.000570. Epub 2011 Sep 6. Review.

13.

IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Feng J, Wang H, Shin DM, Masiuk M, Qi CF, Morse HC 3rd.

J Immunol. 2011 Feb 1;186(3):1458-66. doi: 10.4049/jimmunol.1001950. Epub 2010 Dec 22.

14.

Progenitor cell origin plays a role in fate choices of mature B cells.

Fossati V, Kumar R, Snoeck HW.

J Immunol. 2010 Feb 1;184(3):1251-60. doi: 10.4049/jimmunol.0901922. Epub 2009 Dec 28.

15.

Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.

Li Z, Wang H, Xue L, Shin DM, Roopenian D, Xu W, Qi CF, Sangster MY, Orihuela CJ, Tuomanen E, Rehg JE, Cui X, Zhang Q, Morse HC 3rd, Morris SW.

Blood. 2009 Nov 5;114(19):4158-68. doi: 10.1182/blood-2008-12-192583. Epub 2009 Aug 20.

16.

Killer B lymphocytes: the evidence and the potential.

Lundy SK.

Inflamm Res. 2009 Jul;58(7):345-57. doi: 10.1007/s00011-009-0014-x. Epub 2009 Mar 5. Review.

17.

Peripheral blood CD5-positive B lymphocytes (B-1a cells) after allogeneic stem cell transplantation for acute myeloid leukaemia in humans.

Veneri D, Franchini M, de Sabata D, Ledro S, Vella A, Ortolani R, Pizzolo G, Benedetti F.

Blood Transfus. 2008 Oct;6(4):220-4.

18.

The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies.

Zhou ZH, Zhang Y, Hu YF, Wahl LM, Cisar JO, Notkins AL.

Cell Host Microbe. 2007 Mar 15;1(1):51-61.

19.

Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation.

Ding C, Liu Y, Wang Y, Park BK, Wang CY, Zheng P, Liu Y.

PLoS One. 2007 Oct 3;2(10):e997.

20.

Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors.

Rowley B, Tang L, Shinton S, Hayakawa K, Hardy RR.

J Autoimmun. 2007 Dec;29(4):236-45. Epub 2007 Sep 21.

Supplemental Content

Support Center